Cargando…

Long-term macrolide therapy for chronic obstructive pulmonary disease: a population-based time series analysis

BACKGROUND: Macrolides are recommended as an adjunctive treatment for patients with moderate to severe chronic obstructive pulmonary disease (COPD) who experience recurrent exacerbations. The objective of this study was to examine temporal trends in the provision of long-term macrolide therapy, spec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Marie, Saxena, Farah E., Calzavara, Andrew, Brown, Kevin A., Garber, Gary, Gershon, Andrea S., Johnstone, Jennie, Kumar, Matthew, Langford, Bradley J., Lee, Samantha, Schwartz, Kevin L., Daneman, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Joule Inc. 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177912/ https://www.ncbi.nlm.nih.gov/pubmed/34021016 http://dx.doi.org/10.9778/cmajo.20200157

Ejemplares similares

The Ontario Program To Improve AntiMIcrobial USE (OPTIMISE): A Descriptive Analysis of Dispensed Antibiotics
por: Schwartz, Kevin, et al.
Publicado: (2017)

973. Inter-facility Patient Sharing and Clostridium difficile Incidence in the Ontario Hospital Network: A 13-Year Longitudinal Cohort Study of 116 Hospitals
por: Brown, Kevin, et al.
Publicado: (2018)

Validating a popular outpatient antibiotic database to reliably identify high prescribing physicians for patients 65 years of age and older
por: Schwartz, Kevin L., et al.
Publicado: (2019)

Concordance between high antibiotic prescribing and high opioid prescribing among primary care physicians: a cross-sectional study
por: Langford, Bradley J., et al.
Publicado: (2021)

2369. Prescribing Choices and C. difficile Infection Risk: A Longitudinal Cohort Study of Nursing Home Residents in Ontario, Canada
por: Antoine. Brown, Kevin, et al.
Publicado: (2019)

Antibiotic susceptibility of urine culture specimens in Ontario: a population-based cohort study
por: Marchand-Austin, Alex, et al.
Publicado: (2022)

Antimicrobial resistance and mortality following E. coli bacteremia
por: Daneman, Nick, et al.
Publicado: (2022)

Antibiotic Selection and Duration for Catheter-Associated Urinary Tract Infection in Non-Hospitalized Older Adults: A Population-Based Cohort Study
por: Langford, Bradley J., et al.
Publicado: (2023)

Antimicrobial Stewardship Programs in Long‐Term Care Settings: A Meta‐Analysis and Systematic Review
por: Wu, Julie Hui‐Chih, et al.
Publicado: (2018)

Comparison of qPCR versus culture for the detection and quantification of Clostridium difficile environmental contamination
por: MacDougall, Laura K., et al.
Publicado: (2018)

Virtual learning collaboratives to improve urine culturing and antibiotic prescribing in long-term care: controlled before-and-after study
por: Chambers, Andrea, et al.
Publicado: (2022)

2277. Variability in Changes in Physician Outpatient Antibiotic Prescribing from 2019 to 2021 during the COVID-19 Pandemic in Ontario, Canada
por: Tandon, Pranav, et al.
Publicado: (2023)

Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019)

Variability in changes in physician outpatient antibiotic prescribing from 2019 to 2021 during the COVID-19 pandemic in Ontario, Canada
por: Tandon, Pranav, et al.
Publicado: (2023)

Role of macrolide therapy in chronic obstructive pulmonary disease
por: Martinez, Fernando J, et al.
Publicado: (2008)

Nursing home crowding and its association with outbreak-associated respiratory infection in Ontario, Canada before the COVID-19 pandemic (2014–19): a retrospective cohort study
por: Leece, Pamela, et al.
Publicado: (2023)

Behavioral Nudges to Improve Audit and Feedback Report Opening Among Antibiotic Prescribers: A Randomized Controlled Trial
por: Daneman, Nick, et al.
Publicado: (2022)

388. Does This Patient Have C. difficile Infection? A Systematic Review and Meta-Analysis
por: Manzoor, Fizza, et al.
Publicado: (2022)

Current status and inspiration on macrolides in the treatment of chronic obstructive pulmonary disease
por: Qiu, Shi-lin, et al.
Publicado: (2015)

Macrolides: a promising pharmacologic therapy for chronic obstructive pulmonary disease
por: Qiu, Shilin, et al.
Publicado: (2016)

Population-based evaluation of the effectiveness of nirmatrelvir–ritonavir for reducing hospital admissions and mortality from COVID-19
por: Schwartz, Kevin L., et al.
Publicado: (2023)

Antibiotic prescribing guideline recommendations in COVID-19: a systematic survey
por: Langford, Bradley J., et al.
Publicado: (2023)

The Impact of COVID-19 on Outpatient Antibiotic Prescriptions in Ontario, Canada; An Interrupted Time Series Analysis
por: Kitano, Taito, et al.
Publicado: (2021)

Prophylactic Use of Macrolide Antibiotics for the Prevention of Chronic Obstructive Pulmonary Disease Exacerbation: A Meta-Analysis
por: Ni, Wentao, et al.
Publicado: (2015)

Community pharmacist prescribing of antimicrobials: A systematic review from an antimicrobial stewardship perspective
por: Wu, Julie Hui-Chih, et al.
Publicado: (2021)

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae
por: Domon, Hisanori, et al.
Publicado: (2023)

1759. Incidence of Hospitalizations and Emergency Department Visits for Herpes Zoster in Immunocompromised and Immunocompetent Adults in Ontario, Canada, 2002–2016
por: Buchan, Sarah, et al.
Publicado: (2019)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Macrolide Allergic Reactions
por: Shaeer, Kristy M., et al.
Publicado: (2019)

893 Vancomycin Resistant Enterococcus (VRE) Rates in Ontario, Canada After the Discontinuation of VRE Screening and Control Practices by Some Hospitals: Interim Results
por: Lam, Freda, et al.
Publicado: (2014)

The Magnitude and Duration of Clostridium difficile Infection Risk Associated with Antibiotic Therapy: A Hospital Cohort Study
por: Brown, Kevin A., et al.
Publicado: (2014)

1325. Macrolide versus Non-macrolide in Combination with Steroids for the Treatment of Lobar or Segmental Mycoplasma Pneumoniae Pneumonia Unresponsive to Initial Macrolide Monotherapy
por: Bae, Eunha, et al.
Publicado: (2022)

Comparative safety of inhaled corticosteroids and macrolides in Medicare enrolees with bronchiectasis
por: Henkle, Emily, et al.
Publicado: (2022)

Outcomes Following Macrolide Use in Kidney Transplant Recipients
por: Jeong, Rachel, et al.
Publicado: (2019)

VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis
por: Prematunge, Chatura, et al.
Publicado: (2015)

1684. Clinical Comparison of Pertussis Infected with Macrolides-resistance and Macrolides-sensitive Bordetella Pertussis
por: Guo, Fengwei, et al.
Publicado: (2023)

Long-term macrolides in diffuse interstitial lung diseases
por: Faverio, Paola, et al.
Publicado: (2017)

Macrolide-Resistant Shigella sonnei
por: Boumghar-Bourtchai, Leyla, et al.
Publicado: (2008)

Atypical Bacteria and Macrolides in Asthma
por: Xepapadaki, Paraskevi, et al.
Publicado: (2008)

Macrolide resistance in Streptococcus species
por: Ilakkiya, A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pbbiqptovb0jhuedcdutj36oed